CONSOLIDATED STATEMENTS OF CHANGES IN SHAREHOLDERS’ EQUITY - USD ($) $ in Thousands	Shares of Common Stock	Common Stock and Additional Paid in Capital	Retained Earnings	Accumulated Other Comprehensive Income (Loss)	Total
Balance, beginning of period at Dec. 31, 2018		$ 129,066	$ 23,466	$ (463)	$ 152,069
Balance (in shares) at Dec. 31, 2018	10,712,745
Increase (Decrease) in Shareholders' Equity
Net income			3,167		3,167
Other comprehensive income (loss):
Net unrealized gain on securities available for sale				658	658
Total comprehensive income			3,167	658	3,825
Stock compensation		138			138
Restricted stock award vesting (in shares)	27,967
Dividend on common stock			(1,286)		(1,286)
Balance, end of period at Mar. 31, 2019		129,204	25,347	195	154,746
Balance (in shares) at Mar. 31, 2019	10,740,712
Balance, beginning of period at Dec. 31, 2019		129,564	31,740	615	161,919
Balance (in shares) at Dec. 31, 2019	10,748,712
Increase (Decrease) in Shareholders' Equity
Net income			3,051		3,051
Other comprehensive income (loss):
Net unrealized gain on securities available for sale				(874)	(874)
Total comprehensive income			3,051	(874)	2,177
Stock compensation		168			168
Restricted stock award vesting (in shares)	25,521
Repurchase of common stock		(2,729)			$ (2,729)
Repurchase of common stock (in shares)	(240,644)				240,644
Dividend on common stock			(1,475)		$ (1,475)
Balance, end of period at Mar. 31, 2020		$ 127,003	$ 33,316	$ (259)	$ 160,060
Balance (in shares) at Mar. 31, 2020	10,533,589